Analysed TRANSGENE SA (TRGNF:OTCMKTS) News Sources
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
13-04-2026
yahoo.com
Why Transgene (ENXTPA:TNG) Analysts Are Rewriting The Story Around Its €1.10 Valuation
09-04-2026
yahoo.com
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
02-04-2026
yahoo.com
Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress
26-03-2026
yahoo.com
Transgene SA (STU:TGNA) Full Year 2025 Earnings Call Highlights: Strategic Financial Moves and ...
24-03-2026
yahoo.com
Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028
24-03-2026
yahoo.com
What is the current price of TRANSGENE SA (TRGNF:OTCMKTS)?
The current price of TRANSGENE SA (TRGNF:OTCMKTS) is $0.
TRANSGENE SA (TRGNF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of TRANSGENE SA (TRGNF:OTCMKTS) since the previous trading day is $None.
TRANSGENE SA (TRGNF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of TRANSGENE SA (TRGNF:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for TRANSGENE SA (TRGNF:OTCMKTS)?
The most recent average sentiment score for TRANSGENE SA (TRGNF:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for TRANSGENE SA (TRGNF:OTCMKTS)?
The most recent sentiment for TRANSGENE SA (TRGNF:OTCMKTS) is .
SEC-8K** Filing Available For TRANSGENE SA (TRGNF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.